Impact of sodium-glucose cotransporter-2 inhibitors on kidney outcomes in type 2 diabetes: A tertiary center experience

• Principais autores: Mohammed H Tawhari (Autor), Raed A Aldahash (Autor), Faisal M Almutairi (Autor), Mahdi S Albogami (Autor), Ahmad E Rokon (Autor), Faisal A Alsomali (Autor), Khaled H Alanazi (Autor), Abdulrahman A Alshehri (Autor), Talal H Almutairi (Autor), Abdulrahman D Alharbi (Autor), Rayan M Alghamdi (Autor), Ibrahim H Tawhari (Autor), Salih A Bin Salih (Autor)
• Formato: Livro
• Publicado em: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

BACKGROUND: Diabetic nephropathy (DN) is a complication of chronic hyperglycemia associated with diabetes mellitus (DM). Several studies have demonstrated the positive impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on kidney outcomes. The objective of the study was to evaluate the effec...